The FDA converted Keytruda's accelerated approval for TMB-high solid tumors to traditional approval, raising the eligibility cutoff from 10 to 13 mutations per megabase.

Genetic sequencing from a Utah mink farm found the PB1-K388R mutation in all 10 H5N1 samples, while officials report no human-to-human spread and low public risk.

A University of Pennsylvania analysis of Reddit posts found increased appetite was the most common symptom reported by people using unapproved, online-sold retatrutide, though the study cannot establish causation.

Federal prosecutors charged 15 people in six alleged Los Angeles-area health care fraud schemes involving nearly $2 billion in insurance claims, including cases affecting Medicare, Medi-Cal and hospice patients.

Mood drinks are becoming popular nonalcoholic alternatives, but research does not yet show they reliably improve mood. Experts also warn about side effects, medication interactions and misleading claims.

The FDA says Calibrate IV Hydration marketed unapproved stem cell and exosome products. The warning highlights regulatory concerns and questions consumers should ask before receiving an infusion.

The FDA approved talazoparib with enzalutamide for HRR-mutated, hormone-sensitive metastatic prostate cancer after TALAPRO-3 showed slower progression, though survival remains uncertain and anemia is common.

The FDA alerted dialysis clinics to stop using and return three lots of B. Braun Streamline bloodline tubing after a skipped assembly step raised risks of leaks, blood loss and air entering the circuit.

The CDC says U.S. flu activity is rising earlier than usual, with increasing test positivity and hospitalizations, though it is too soon to predict the season's severity.

A recall of Miyoko's salted vegan butter has prompted conflicting state and risk listings. Shoppers should check packages for the affected UPC, lots and best-by date.